ProfLeonie Young
Professor
Department of Surgery
Orcid identifier0000-0002-4904-0367 (opens in a new tab)
- ProfessorDepartment of Surgery
- 01 4028576 (Work)
- RCSI, Surgery, York House - York Street, Dublin 2
RESEARCH OVERVIEW
Translational studies from our group and others have provided significant evidence of a significant role for Steroid Receptor Coactivator (SRC) proteins in the development of resistance to endocrine therapy in breast cancer. Subsequently, we have created a tissue microarray (TMA) of 500 patients with known clinical parameters which we will utilise to assess expression of ER-alpha, ER-beta, SRC-1 and SRC-3 in paraffin-embedded breast cancer tissue by immunohistochemistry. Intracellular localisation of the nuclear receptors and co-activators will be assessed by immunofluorescence and the sections examined by confocal microscopy. We then propose to undertake in-situ fluorescence resonance energy transfer (FRET) experiments to elucidate interactions between ER isoforms and co-activator proteins in breast cancer tissue. Nuclear receptor-co-activator interactions will be correlated with clinicopathological parameters and disease outcome.Uniquely, this study will utilise primary cell cultures derived from patient tumours, thus providing samples not readily available in most molecular model systems. 3D ascini will be cultured ex vivo from primary cells derived from patient tumours to enable the investigation of nuclear receptor and co-activator expression in ductal structures. Spatial trans-localisation of nuclear receptors and co-activator proteins in resultant epithelial ducts in response to endocrine treatments will be determined by confocal live-cell imaging systems.
GRANTS
- FUNDED PROJECTStudent Selected Projects (SSP) 2027RCSI1 Oct 2026 - 30 Sep 2027
- FUNDED PROJECTStudent Selected Projects (SSP) 2026RCSI9 Feb 2026 - 21 Dec 2026
- FUNDED PROJECTHER2-CNS SurveillanceBreast Cancer Ireland1 Oct 2025 - 30 Sep 2027
- FUNDED PROJECTPrecision Oncology Ireland-2 (POI2)Research Ireland1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTResearch Ireland - Precision Oncology Ireland 2 (POI2) Co-FundRCSI1 Oct 2025 - 30 Sep 2031
- FUNDED PROJECTTargeted treatment resistance in metastatic breast cancer - Phase 2Breast Cancer Ireland1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTCAMBRIA-2 Consultancy FundsIndustry – Consultancy-Economic Activity25 Jun 2025 - 24 Jun 2027
- FUNDED PROJECTARC Hub for Therapeutic InnovationScience Foundation Ireland (SFI)1 Jan 2025 - 31 Dec 2029
- FUNDED PROJECTResearch Ireland (formerly IRC) 2025 Supplementary StipendResearch Ireland1 Jan 2025 - 31 Dec 2025
- FUNDED PROJECTResearch Ireland (formerly SFI) 2025 Supplementary StipendResearch Ireland1 Jan 2025 - 31 Dec 2025
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTAcquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)Industry – Co-Funded Collaborative Research – RCSI owns IP1 Aug 2024 - 31 Jul 2028
- FUNDED PROJECTStudent Selected Projects (SSP) 2024RCSI29 Apr 2024 - 28 Apr 2025
- FUNDED PROJECTAvril Watters Breast Cancer Ireland ScholarshipBreast Cancer Ireland1 Jan 2024 - 31 Dec 2026
- FUNDED PROJECTSFI PhD 2024 Additional Stipend AllowanceScience Foundation Ireland (SFI)1 Jan 2024 - 31 Dec 2024
- FUNDED PROJECTBlue Organoids for Treatment Selection (BOTS)European Union / EU31 Dec 2023 - 30 Dec 2026
- FUNDED PROJECTA randomised interventional study to examine whether communication of expected timeframes between points of the cancer pathway has an impact on patient reported experience and overall outcomesIrish Research Council IRC1 Sep 2023 - 31 Aug 2026People funded by this grant:
- Claire N
- FUNDED PROJECTCollaborative Initiative 2023/24RCSI1 Sep 2023 - 31 Aug 2025
- FUNDED PROJECTIntegration of aberrant gene expression and spatial genomics to identify new druggable targets to treat breast cancer brain metastasisIrish Research Council IRC1 Sep 2023 - 31 Aug 2026